Pharmaceutical Manufacturing Market Report 2026

Pharmaceutical Manufacturing Market Overview

• Pharmaceutical Manufacturing market size has reached to $572.33 billion in 2025 • Expected to grow to $923.47 billion in 2030 at a compound annual growth rate (CAGR) of 10% • Growth Driver: Rising Demand For Scalable Healthcare Solutions Due To Increasing Burden Of Chronic Illnesses • Market Trend: Advancing Production Capabilities Through Automation And Technological Innovation • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pharmaceutical Manufacturing Market?

Pharmaceutical manufacturing is the industrial process of developing, producing, and packaging medications and medical products at scale through chemical synthesis, biological processing, and formulation of active and inactive ingredients, carried out under stringent regulatory and quality control standards to ensure the safety, efficacy, consistency, and compliance of drugs intended for human and veterinary use across global healthcare systems. The main molecule types of pharmaceutical manufacturing include biologics and biosimilars, and conventional drugs. Tablets are solid, flat medications that contain a specified amount of active chemicals. Formulations include tablets, capsules, injectables, sprays, suspensions, powders, and others, and are administered through various routes, such as oral, topical, parenteral, inhalation, and others. It serves multiple therapy areas, including cardiovascular diseases (CVDs), pain, diabetes, cancer, respiratory diseases, and others, and is distributed through retail and non-retail sales channels.

What Is The Pharmaceutical Manufacturing Market Growth Forecast?

The pharmaceutical manufacturing market size is expected to see strong growth in the next few years. It will grow to $923.47 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing investments in smart manufacturing facilities, rising adoption of advanced biologics production, expansion of personalized medicine manufacturing, growing focus on cost-efficient production models, increasing integration of digital quality management systems. Major trends in the forecast period include increasing adoption of continuous manufacturing technologies, rising focus on biologics and biosimilars production, expansion of advanced quality control systems, growing integration of automation and robotics, enhanced emphasis on regulatory compliance.

Global Pharmaceutical Manufacturing Market Segmentation

1) By Molecule Type: Biologics And Biosimilars, Conventional Drugs 2) By Formulation: Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Other Formulations 3) By Route Of Administration: Oral, Topical, Parenteral, Inhalations, Other Route Of Administrations 4) By Therapy Area: Cardiovascular Diseases (CVDs), Pain, Diabetes, Cancer, Respiratory Diseases, Other Diseases 5) By Sales Channel: Retail, Non-retail Subsegments: 1) By Biologics And Biosimilars: Monoclonal Antibodies, Vaccines, Recombinant Proteins, Cell Therapies, Gene Therapies, Hormones, Blood And Plasma Products 2) By Conventional Drugs: Analgesics, Antipyretics, Antibiotics, Antivirals, Antifungals, Antihypertensives, Antidepressants, Antidiabetics

What Is The Driver Of The Pharmaceutical Manufacturing Market?

The increasing prevalence of chronic diseases is expected to propel the growth of the pharmaceutical manufacturing market going forward. Chronic diseases are long-lasting health conditions that typically progress slowly and persist for a year or more, often requiring ongoing medical attention or limiting daily activities. The increasing prevalence of chronic diseases is due to rising life expectancy, sedentary lifestyles, and unhealthy dietary habits, leading to greater demand for long-term healthcare solutions and preventive wellness measures. Pharmaceutical manufacturing is useful for chronic diseases by ensuring a steady supply of essential medications, supporting innovation in drug development, and meeting the growing need for effective long-term treatment solutions. For instance, in September 2024, according to the National Health Service, a UK-based government department, 11% of adults aged 35 and older have advanced chronic kidney disease, with prevalence and severity rising with age. Nearly 48% of those aged 75 and above have some form of the disease, and 36% have more severe stages. Therefore, the increasing prevalence of chronic diseases is driving growth in the pharmaceutical manufacturing industry.

Key Players In The Global Pharmaceutical Manufacturing Market

Major companies operating in the pharmaceutical manufacturing market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Inc., Eli Lilly and Company, Gilead Sciences Inc., Novo Nordisk A/S, Lonza Group AG, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories, Cipla Limited, Samsung Biologics, FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Lupin Limited, Jubilant Pharmova Limited.

Global Pharmaceutical Manufacturing Market Trends and Insights

Major companies operating in the pharmaceutical manufacturing market are focusing on developing advanced solutions, such as fully automated RLT manufacturing facilities, to enhance production efficiency, ensure high-quality standards, and meet the growing demand for targeted cancer therapies. An automated RLT manufacturing facility is a state-of-the-art production site that uses advanced automation technologies to streamline and optimize the production of radioligand therapies, ensuring consistent, efficient, and scalable manufacturing. For instance, in January 2024, Novartis AG, a Switzerland-based pharmaceutical corporation, received US Food and Drug Administration (FDA) approval for Pluvicto production at a state-of-the-art radioligand therapy (RLT) manufacturing facility in Indianapolis, which will significantly increase production capacity for its radioligand therapy medicines, including Pluvicto and Lutathera. This expansion is part of Novartis' broader strategy to meet the growing global demand for targeted cancer therapies and improve access for patients worldwide.

What Are Latest Mergers And Acquisitions In The Pharmaceutical Manufacturing Market?

In December 2024, Novo Holdings A/S, a Denmark-based asset management company, acquired Catalent for $16.5 billion. Through this acquisition, Novo Holdings aims to strengthen its position in the life sciences sector by leveraging Catalent's industry-leading expertise in drug development, manufacturing, and clinical supply management to accelerate growth, enhance patient outcomes, and create sustainable value within the pharmaceutical and biotechnology industries. Catalent Inc. is a US-based pharma company that provides pharmaceutical manufacturing services.

Regional Outlook

North America was the largest region in the pharmaceutical manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pharmaceutical Manufacturing Market?

The pharmaceutical manufacturing market consists of revenues earned by entities by providing services such as contract manufacturing, formulation development, quality control and testing, and packaging and labeling. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmaceutical manufacturing market also includes sales of syrups, patch formulations, biologics, and antibiotics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pharmaceutical Manufacturing Market Report 2026?

The pharmaceutical manufacturing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical manufacturing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.